
Bioorganic and Medicinal Chemistry Letters p. 1547 - 1550 (1998)
Update date:2022-07-29
Topics:
Jung, Sang-Hun
Lee, Hui-Soon
Song, Jae-Shin
Kim, Hwan-Mook
Han, Sang-Bae
Lee, Chang-Woo
Lee, Moonsun
Choi, Dong-Rack
Lee, Jung-Ah
Chung, Yong-Ho
Yoon, Sung-June
Moon, Eun-Yi
Hwang, Hyun-Sook
Seong, Seung-Kyoo
Lee, Dug-Keun
Novel 1-(1-benzoylindoline-5-sulfonyl)-4-phenyl-4,5-dihydroimidazolones 3 synthesized show highly potent and broad cytotoxicities. Among them compound 3b (DW2143) exhibits much more potent cytotoxicities than doxorubicin and highly effective antitumor activities against murine (3LL, Colon 26) and human xenograft (NCI-H23, SW620) tumor models.
View MoreZhejiang Haizhou Pharmaceutical Co., Ltd.
website:https://www.haizhoupharma.com/
Contact:+86-576-88221016
Address:No. 19, Donghai 5th Avenue, Yanhai Industrial Zone, Linhai, Zhejiang, China
Xiamen XM-Innovation Chemical Co., Ltd
Contact:+86-592-3216205
Address:Unit Q, 11/F, No.1 Office Building, Wuyuan Bay Business Center, Huli District, Xiamen City, Fujian Province, P.R.C
Shanghai Rich Chemicals Co., Ltd
website:http://www.richchemical.com
Contact:+86-21-20255798
Address:Pudong Shanghai,China
Contact:410-273-7300; 800-221-3953
Address:4609 Richlynn Dr., PO Box 369, Belcamp, MD, 21017-0369, USA
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Doi:10.1016/S0040-4020(98)00069-6
(1998)Doi:10.1016/S0957-4166(98)00014-7
(1998)Doi:10.1016/j.tetasy.2008.04.019
(2008)Doi:10.3987/COM-97-7943
(1997)Doi:10.1016/S0022-1139(97)00147-4
(1998)Doi:10.1016/S0040-4039(00)00300-2
(2000)